Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Cymbalta Approved for Pain Management | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Cymbalta Approved for Pain Management

Eli Lilly and Co. received approval from the FDA for Cymbalta (duloxetine HCl) for the management of chronic musculoskeletal pain.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Eli Lilly and Co. received approval from the FDA for Cymbalta (duloxetine HCl) for the management of chronic musculoskeletal pain. This indication was established in studies in patients with chronic low back pain and chronic pain due to osteoarthritis. This is Cymbalta’s fifth indication approved by the FDA.

Cymbalta, a non-narcotic pain reliever, has been shown to significantly reduce chronic low back pain and chronic pain due to osteoarthritis. It is believed that Cymbalta helps lessen pain by enhancing the body’s natural pain suppressing system by increasing the activity of serotonin and norepinephrine in the brain and spinal cord. The most commonly observed adverse events in Cymbalta-treated patients with chronic pain due to osteoarthritis were nausea, fatigue and constipation.

“It’s important that people with chronic musculoskeletal pain have different treatments available to them because responses to medications can be highly individualized,” said Robert Baker, M.D., global development leader for psychiatry and pain disorders at Lilly. “This is why we are happy to be able to provide doctors and patients with a new option.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters